Literature DB >> 9483437

Treatment of thrombus containing lesions in diseased native coronary arteries and saphenous vein bypass grafts using the AngioJet Rapid Thrombectomy System.

J N Hamburger1, P W Serruys.   

Abstract

The occurrence of fresh thrombus during percutaneous coronary interventions, especially in patients with diffusely diseased saphenous vein bypass grafts is associated with an increased incidence of procedural complications and clinical events. The AngioJet Rapid Thrombectomy Catheter was designed to remove thrombus via a Bernoulli effect induced vacuum. Here we report on the technical aspects of the device and the AngioJet thrombectomy procedure. Indications and potential complications, both procedure- and device related are discussed.

Entities:  

Mesh:

Year:  1997        PMID: 9483437     DOI: 10.1007/BF03044282

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  16 in total

1.  The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings.

Authors: 
Journal:  N Engl J Med       Date:  1985-04-04       Impact factor: 91.245

2.  Clinical and angiographic implications of coronary stenting in thrombus-containing lesions.

Authors:  F Alfonso; P Rodriguez; P Phillips; J Goicolea; R Hernández; M J Pérez-Vizcayno; A Fernández-Ortiz; J Segovia; C Bañuelos; P Aragoncillo; C Macaya
Journal:  J Am Coll Cardiol       Date:  1997-03-15       Impact factor: 24.094

3.  Intracoronary stent insertion after balloon angioplasty of chronic total occlusions.

Authors:  S L Goldberg; A Colombo; L Maiello; M Borrione; L Finci; Y Almagor
Journal:  J Am Coll Cardiol       Date:  1995-09       Impact factor: 24.094

4.  Comparative results of transluminal extraction coronary atherectomy in saphenous vein graft lesions with and without thrombus.

Authors:  M Dooris; M Hoffmann; S Glazier; N Juran; V Reddy; C L Grines; G S Pavlides; T Schreiber; W W O'Neill; R D Safian
Journal:  J Am Coll Cardiol       Date:  1995-06       Impact factor: 24.094

5.  Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty.

Authors: 
Journal:  N Engl J Med       Date:  1994-04-07       Impact factor: 91.245

6.  Angioscopic versus angiographic detection of thrombus during coronary interventional procedures.

Authors:  P S Teirstein; R A Schatz; S J DeNardo; E E Jensen; A D Johnson
Journal:  Am J Cardiol       Date:  1995-06-01       Impact factor: 2.778

7.  Intracoronary thrombus: role in coronary occlusion complicating percutaneous transluminal coronary angioplasty.

Authors:  T A Mabin; D R Holmes; H C Smith; R E Vlietstra; A A Bove; G S Reeder; J H Chesebro; J F Bresnahan; T A Orszulak
Journal:  J Am Coll Cardiol       Date:  1985-02       Impact factor: 24.094

8.  Treatment of intracoronary thrombus with local urokinase infusion using a new, site-specific drug delivery system: the Dispatch catheter.

Authors:  R G McKay; D B Fram; J A Hirst; F J Kiernan; C A Primiano; M J Rinaldi; M A Azrin; J F Mitchel; D D Waters
Journal:  Cathet Cardiovasc Diagn       Date:  1994-10

9.  Angioplasty of complex lesions in ischemic rest angina: results of the Thrombolysis and Angioplasty in Unstable Angina (TAUSA) trial.

Authors:  R Mehran; J A Ambrose; R M Bongu; O D Almeida; D H Israel; S Torre; S K Sharma; D E Ratner
Journal:  J Am Coll Cardiol       Date:  1995-10       Impact factor: 24.094

10.  Prolonged intracoronary infusion of streptokinase: an alternative pharmacologic approach to extensive thrombus in native coronary artery.

Authors:  O Kjellgren; J R Wilentz; L Kaganovsky; W Sherman
Journal:  Cathet Cardiovasc Diagn       Date:  1994-09
View more
  1 in total

1.  Embolic protection devices.

Authors:  G Sangiorgi; A Colombo
Journal:  Heart       Date:  2003-09       Impact factor: 5.994

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.